JP2023539356A5 - - Google Patents
Info
- Publication number
- JP2023539356A5 JP2023539356A5 JP2023514163A JP2023514163A JP2023539356A5 JP 2023539356 A5 JP2023539356 A5 JP 2023539356A5 JP 2023514163 A JP2023514163 A JP 2023514163A JP 2023514163 A JP2023514163 A JP 2023514163A JP 2023539356 A5 JP2023539356 A5 JP 2023539356A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acids
- protein
- modified
- coronavirus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063073327P | 2020-09-01 | 2020-09-01 | |
| US63/073,327 | 2020-09-01 | ||
| US202163211716P | 2021-06-17 | 2021-06-17 | |
| US63/211,716 | 2021-06-17 | ||
| PCT/CA2021/051201 WO2022047575A1 (en) | 2020-09-01 | 2021-08-31 | Modified coronavims structural protein |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023539356A JP2023539356A (ja) | 2023-09-13 |
| JP2023539356A5 true JP2023539356A5 (https=) | 2024-09-17 |
Family
ID=80492282
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023514163A Pending JP2023539356A (ja) | 2020-09-01 | 2021-08-31 | 改変コロナウイルス構造タンパク質 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240226271A1 (https=) |
| EP (1) | EP4208484A4 (https=) |
| JP (1) | JP2023539356A (https=) |
| KR (1) | KR20230079057A (https=) |
| AU (1) | AU2021335378A1 (https=) |
| CA (1) | CA3191257A1 (https=) |
| IL (1) | IL300958A (https=) |
| MX (1) | MX2023002505A (https=) |
| PY (1) | PY2175039A (https=) |
| TW (1) | TW202229317A (https=) |
| UY (1) | UY39400A (https=) |
| WO (1) | WO2022047575A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023010176A1 (en) * | 2021-08-04 | 2023-02-09 | The University Of Melbourne | Vaccine construct and uses thereof |
| JP2026501447A (ja) * | 2022-12-16 | 2026-01-15 | ジーニアス・バイオテクノロジー・インコーポレイテッド | 多重抗原性ｒｎａ ｓａｒｓ－ｃｏｖ－２ワクチン及び関連する方法 |
| WO2025106425A1 (en) * | 2023-11-13 | 2025-05-22 | University Of Florida Research Foundation, Incorporated | Immunogenic composition and uses thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI526539B (zh) * | 2010-12-22 | 2016-03-21 | 苜蓿股份有限公司 | 植物中生產類病毒顆粒(vlp)的方法及以該方法生產之vlp |
| WO2018115527A2 (en) * | 2016-12-23 | 2018-06-28 | Curevac Ag | Mers coronavirus vaccine |
-
2021
- 2021-08-31 CA CA3191257A patent/CA3191257A1/en active Pending
- 2021-08-31 AU AU2021335378A patent/AU2021335378A1/en active Pending
- 2021-08-31 MX MX2023002505A patent/MX2023002505A/es unknown
- 2021-08-31 KR KR1020237010167A patent/KR20230079057A/ko active Pending
- 2021-08-31 EP EP21863146.3A patent/EP4208484A4/en active Pending
- 2021-08-31 IL IL300958A patent/IL300958A/en unknown
- 2021-08-31 WO PCT/CA2021/051201 patent/WO2022047575A1/en not_active Ceased
- 2021-08-31 US US18/024,140 patent/US20240226271A1/en active Pending
- 2021-08-31 JP JP2023514163A patent/JP2023539356A/ja active Pending
- 2021-08-31 UY UY0001039400A patent/UY39400A/es unknown
- 2021-09-01 PY PY202102175039A patent/PY2175039A/es unknown
- 2021-09-01 TW TW110132402A patent/TW202229317A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7250878B2 (ja) | 新規多価ナノ粒子に基づくワクチン | |
| US20240075125A1 (en) | Expression systems | |
| KR102920353B1 (ko) | 나노입자-기반 인플루엔자 바이러스 백신 및 이의 용도 | |
| JP2023539356A5 (https=) | ||
| Phan et al. | ELP ylated haemagglutinins produced in tobacco plants induce potentially neutralizing antibodies against H5N 1 viruses in mice | |
| EP3160501B1 (en) | Influenza virus hemagglutinin protein as a vaccine antigen | |
| JP2013526849A5 (https=) | ||
| KR20080028941A (ko) | 재조합 인플루엔자 백신 | |
| TW201520221A (zh) | 穩定化可溶性融合前ｒｓｖ ｆ多肽 | |
| WO2011103453A2 (en) | Vaccines for use in the prophylaxis and treatment of influenza virus disease | |
| JP2012521786A5 (https=) | ||
| JP2011528223A5 (https=) | ||
| JP2008524261A5 (https=) | ||
| CN105408347A (zh) | 寡聚流感免疫原性组合物 | |
| TW201008576A (en) | New fusion proteins and their use for the preparation of vaccines against hepatitis C | |
| KR101034490B1 (ko) | 생체 안전성이 뛰어난 인플루엔자 바이러스 백신용 항원성 에피토프로서의 재조합 헤마글루티닌 단백질 | |
| CN115850395A (zh) | 一种流感病毒通用型纳米颗粒疫苗及其制备方法 | |
| WO2009133463A1 (en) | Soluble influenza vaccine | |
| WO2016179099A4 (en) | Modified h7 hemagluttinin glycoprotein of the influenza a/shanghai/2/2013 h7 sequence | |
| CN102174090B (zh) | 一种猪源a型流感病毒头部蛋白及其制备方法和应用 | |
| Kotlyarov et al. | Development of recombinant vaccine against A (H1N1) 2009 influenza based on virus-like nanoparticles carrying the extracellular domain of M2 protein | |
| CN118725052A (zh) | 具有稳定融合前构象的呼吸道合胞病毒f蛋白 | |
| Van et al. | Bio-functional enhancement of plant based-haemagglutinin by fusion with IgMFc | |
| Utomo et al. | An Overview of Recent Developments in the Application of Antigen Displaying Vaccine Platforms: Hints for Future SARS-CoV-2 VLP Vaccines. Vaccines 2023, 11, 1506 | |
| Choi et al. | Immune response induced by the TAT-conjugated influenza M2e in mice |